First Trust Advisors’s Integra LifeSciences IART Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-169,080
| Closed | -$2.42M | – | 2668 |
|
|
2025
Q3 | $2.42M | Buy |
169,080
+114,462
| +210% | +$1.57M | ﹤0.01% | 1748 |
|
|
2025
Q2 | $670K | Sell |
54,618
-9,555
| -15% | -$139K | ﹤0.01% | 2186 |
|
|
2025
Q1 | $1.41M | Sell |
64,173
-122,127
| -66% | -$2.87M | ﹤0.01% | 1920 |
|
|
2024
Q4 | $4.23M | Buy |
186,300
+141,907
| +320% | +$3.1M | ﹤0.01% | 1457 |
|
|
2024
Q3 | $807K | Sell |
44,393
-432,162
| -91% | -$10M | ﹤0.01% | 2070 |
|
|
2024
Q2 | $13.9M | Buy |
476,555
+81,571
| +21% | +$2.42M | 0.01% | 910 |
|
|
2024
Q1 | $14M | Sell |
394,984
-166,916
| -30% | -$6.68M | 0.01% | 915 |
|
|
2023
Q4 | $24.5M | Sell |
561,900
-85,392
| -13% | -$3.36M | 0.03% | 688 |
|
|
2023
Q3 | $24.7M | Buy |
647,292
+397,110
| +159% | +$16.7M | 0.03% | 630 |
|
|
2023
Q2 | $10.3M | Sell |
250,182
-15,468
| -6% | -$744K | 0.01% | 1006 |
|
|
2023
Q1 | $15.3M | Sell |
265,650
-152,677
| -36% | -$8.6M | 0.02% | 844 |
|
|
2022
Q4 | $23.5M | Buy |
418,327
+138,315
| +49% | +$7.04M | 0.03% | 648 |
|
|
2022
Q3 | $11.9M | Buy |
280,012
+58,545
| +26% | +$3M | 0.02% | 898 |
|
|
2022
Q2 | $12M | Buy |
221,467
+5,196
| +2% | +$312K | 0.01% | 892 |
|
|
2022
Q1 | $13.9M | Buy |
216,271
+73,217
| +51% | +$4.82M | 0.01% | 942 |
|
|
2021
Q4 | $9.58M | Sell |
143,054
-63,758
| -31% | -$4.31M | 0.01% | 1079 |
|
|
2021
Q3 | $14.2M | Buy |
206,812
+21,308
| +11% | +$1.51M | 0.02% | 898 |
|
|
2021
Q2 | $12.7M | Buy |
185,504
+176,402
| +1,938% | +$12.5M | 0.01% | 938 |
|
|
2021
Q1 | $629K | Buy |
+9,102
| New | +$617K | ﹤0.01% | 2138 |
|
|
2020
Q3 | – | Sell |
-25,205
| Closed | -$1.18M | – | 2395 |
|
|
2020
Q2 | $1.18M | Buy |
25,205
+16,086
| +176% | +$791K | ﹤0.01% | 1659 |
|
|
2020
Q1 | $407K | Sell |
9,119
-37,582
| -80% | -$1.97M | ﹤0.01% | 2005 |
|
|
2019
Q4 | $2.72M | Buy |
46,701
+16,638
| +55% | +$990K | ﹤0.01% | 1403 |
|
|
2019
Q3 | $1.81M | Sell |
30,063
-181,236
| -86% | -$10.8M | ﹤0.01% | 1595 |
|
|
2019
Q2 | $11.8M | Buy |
211,299
+190,626
| +922% | +$9.82M | 0.02% | 717 |
|
|
2019
Q1 | $1.15M | Sell |
20,673
-531,876
| -96% | -$27.1M | ﹤0.01% | 1804 |
|
|
2018
Q4 | $24.9M | Buy |
552,549
+162,829
| +42% | +$8.93M | 0.06% | 421 |
|
|
2018
Q3 | $25.7M | Buy |
389,720
+321,619
| +472% | +$20M | 0.05% | 505 |
|
|
2018
Q2 | $4.39M | Buy |
+68,101
| New | +$4.22M | 0.01% | 1164 |
|
|
2018
Q1 | – | Sell |
-18,879
| Closed | -$904K | – | 2337 |
|
|
2017
Q4 | $904K | Sell |
18,879
-32,205
| -63% | -$1.58M | ﹤0.01% | 1890 |
|
|
2017
Q3 | $2.58M | Buy |
51,084
+34,925
| +216% | +$1.79M | 0.01% | 1310 |
|
|
2017
Q2 | $881K | Sell |
16,159
-20,279
| -56% | -$968K | ﹤0.01% | 1892 |
|
|
2017
Q1 | $1.53M | Buy |
36,438
+1,182
| +3% | +$50.5K | ﹤0.01% | 1651 |
|
|
2016
Q4 | $1.51M | Sell |
35,256
-16,414
| -32% | -$667K | ﹤0.01% | 1619 |
|
|
2016
Q3 | $2.13M | Buy |
51,670
+12,204
| +31% | +$511K | 0.01% | 1300 |
|
|
2016
Q2 | $1.57M | Buy |
39,466
+1,762
| +5% | +$63.4K | 0.01% | 1430 |
|
|
2016
Q1 | $1.27M | Sell |
37,704
-1,366
| -3% | -$42.5K | ﹤0.01% | 1557 |
|
|
2015
Q4 | $1.32M | Sell |
39,070
-48,674
| -55% | -$1.52M | ﹤0.01% | 1626 |
|
|
2015
Q3 | $2.61M | Sell |
87,744
-22,670
| -21% | -$709K | 0.01% | 1255 |
|
|
2015
Q2 | $3.04M | Buy |
110,414
+56,890
| +106% | +$1.52M | 0.01% | 1282 |
|
|
2015
Q1 | $1.35M | Sell |
53,524
-45,514
| -46% | -$1.08M | ﹤0.01% | 1641 |
|
|
2014
Q4 | $2.19M | Buy |
99,038
+45,377
| +85% | +$920K | 0.01% | 1400 |
|
|
2014
Q3 | $1.09M | Buy |
+53,661
| New | +$1.07M | ﹤0.01% | 1666 |
|
|
2014
Q2 | – | Sell |
-25,967
| Closed | -$488K | – | 2247 |
|
|
2014
Q1 | $488K | Sell |
25,967
-1,150
| -4% | -$22.2K | ﹤0.01% | 1940 |
|
|
2013
Q4 | $529K | Buy |
27,117
+6,750
| +33% | +$124K | ﹤0.01% | 1875 |
|
|
2013
Q3 | $335K | Buy |
20,367
+5,304
| +35% | +$85.1K | ﹤0.01% | 2068 |
|
|
2013
Q2 | $226K | Buy |
+15,063
| New | +$221K | ﹤0.01% | 2123 |
|
Other funds holding IART
RCMNY
PCMI
First Trust Advisors's IART Position: Q4 2025 in Review
First Trust Advisors sold out of Integra LifeSciences (IART) in Q4 2025, closing a stake of 169,080 shares — an estimated $2.42M sold.
First Trust Advisors first reported a position in IART in Q2 2013 and held it in 46 quarters. The position peaked at $25.7M in Q3 2018. 204 funds tracked by Wall St. Rank hold IART as of Q4 2025.
- First Trust Advisors reported no remaining Integra LifeSciences position as of Q4 2025 after selling out during the quarter.
- First Trust Advisors sold 169,080 Integra LifeSciences shares in Q4 2025, an estimated $2.42M.
- First Trust Advisors first reported a position in Integra LifeSciences in Q2 2013 and held it in 46 quarters.
- First Trust Advisors's Integra LifeSciences position peaked at $25.7M in Q3 2018.
- 204 funds tracked by Wall St. Rank held Integra LifeSciences as of Q4 2025.
Based on First Trust Advisors's 13F filing for Q4 2025, filed 13 Feb 2026.